Vivos Therapeutics(股票代码:VVOS)近日宣布,已成功完成与现有私募股权投资者New Seneca Partners的定向增发交易。此次融资将进一步加强公司的资本结构,并为未来业务拓展提供资金支持。
Vivos Therapeutics(股票代码:VVOS)近日宣布,已成功完成与现有私募股权投资者New Seneca Partners的定向增发交易。此次融资将进一步加强公司的资本结构,并为未来业务拓展提供资金支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.